Galera Therapeutics (GRTX) Short Interest Ratio & Short Volume → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free GRTX Stock Alerts $0.18 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Galera Therapeutics Short Interest DataCurrent Short Volume2,790,000 sharesPrevious Short Volume2,660,000 sharesChange Vs. Previous Month+4.89%Dollar Volume Sold Short$519,777.00Short Interest Ratio / Days to Cover1.4Last Record DateApril 30, 2024Outstanding Shares54,390,000 sharesFloat Size37,990,000 sharesShort Percent of Float7.34%Today's Trading Volume1,030,306 sharesAverage Trading Volume1,997,987 sharesToday's Volume Vs. Average52% Short Selling Galera Therapeutics ? Sign up to receive the latest short interest report for Galera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGRTX Short Interest Over TimeGRTX Days to Cover Over TimeGRTX Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Galera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,790,000 shares $519,777.00 +4.9%7.3%1.4 $0.19 4/15/20242,660,000 shares $406,714.00 +50.3%6.5%1.4 $0.15 3/31/20241,770,000 shares $247,800.00 -36.8%4.1%0.7 $0.14 3/15/20242,800,000 shares $591,360.00 -45.0%7.3%1.4 $0.21 2/29/20245,090,000 shares $1.24 million +51.5%13.3%2.5 $0.24 2/15/20243,360,000 shares $613,200.00 -4.0%8.6%1.7 $0.18 Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,500,000 shares $626,500.00 -24.6%9.9%1.9 $0.18 1/15/20244,640,000 shares $997,600.00 +197.4%13.1%1.4 $0.22 12/31/20231,560,000 shares $226,824.00 +12.2%3.7%0.4 $0.15 12/15/20231,390,000 shares $190,430.00 +1.5%3.3%0.4 $0.14 11/30/20231,370,000 shares $195,225.00 -24.7%3.5%0.3 $0.14 11/15/20231,820,000 shares $263,172.00 -36.6%4.5%0.4 $0.14 10/31/20232,870,000 shares $278,677.00 -1.0%8.0%0.5 $0.10 10/15/20232,900,000 shares $553,900.00 -18.3%8.1%0.6 $0.19 9/30/20233,550,000 shares $621,605.00 +73.2%9.9%1 $0.18 9/15/20232,050,000 shares $386,630.00 -15.6%5.7%0.6 $0.19 8/31/20232,430,000 shares $510,300.00 -27.7%6.8%1 $0.21 8/15/20233,360,000 shares $906,864.00 +128.6%9.4%1.4 $0.27 7/31/20231,470,000 shares $3.62 million +32.4%4.2%1.7 $2.46 7/15/20231,110,000 shares $3.05 million +12.8%3.2%1.6 $2.75 6/30/2023984,000 shares $3.07 million +11.8%2.9%1.6 $3.12 6/15/2023880,500 shares $2.98 million +8.4%2.6%1.4 $3.39 5/31/2023812,600 shares $2.49 million -1.7%2.4%1.2 $3.07 5/15/2023826,900 shares $2.63 million No Change2.4%1.1 $3.18 10/31/2022610,400 shares $885,080.00 +17.4%3.4%5 $1.45 10/15/2022519,800 shares $805,690.00 -2.5%2.9%6 $1.55 9/30/2022533,100 shares $927,594.00 +4.5%2.9%6.1 $1.74 9/15/2022510,200 shares $954,074.00 +8.5%2.8%5.4 $1.87 8/31/2022470,100 shares $629,934.00 +2.0%2.6%5.1 $1.34 8/15/2022460,900 shares $672,914.00 -4.9%2.5%5.5 $1.46 7/31/2022484,800 shares $562,368.00 -0.6%2.7%4.7 $1.16 7/15/2022487,900 shares $585,480.00 -8.7%2.7%3.7 $1.20 6/30/2022534,400 shares $694,720.00 -4.0%3.0%3.8 $1.30 6/15/2022556,700 shares $823,916.00 -6.2%3.1%3.8 $1.48 5/31/2022593,500 shares $949,600.00 +11.4%3.3%3.3 $1.60 5/15/2022533,000 shares $804,830.00 -17.5%2.9%2.4 $1.51 4/30/2022645,900 shares $1.09 million +21.0%3.6%2.6 $1.69 4/15/2022534,000 shares $1.14 million +1.9%3.0%1.7 $2.13 3/31/2022524,200 shares $1.25 million -8.0%N/A0 $2.38 3/15/2022569,800 shares $1.20 million -11.1%3.2%0.2 $2.10The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide GRTX Short Interest - Frequently Asked Questions What is Galera Therapeutics' current short interest? Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,790,000 shares of GRTX short. 7.34% of Galera Therapeutics' shares are currently sold short. Learn More on Galera Therapeutics' current short interest. What is a good short interest ratio for Galera Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRTX shares currently have a short interest ratio of 1.0. Learn More on Galera Therapeutics's short interest ratio. What is a good short interest percentage for Galera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.34% of Galera Therapeutics' floating shares are currently sold short. Is Galera Therapeutics' short interest increasing or decreasing? Galera Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 2,790,000 shares, an increase of 4.9% from the previous total of 2,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Galera Therapeutics' float size? Galera Therapeutics currently has issued a total of 54,390,000 shares. Some of Galera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galera Therapeutics currently has a public float of 37,990,000 shares. How does Galera Therapeutics' short interest compare to its competitors? 7.34% of Galera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Galera Therapeutics: Addex Therapeutics Ltd (1.85%), Aeterna Zentaris Inc. (0.34%), Alterity Therapeutics Limited (1.03%), Chemomab Therapeutics Ltd. (0.98%), Guardion Health Sciences, Inc. (14.33%), Molecular Templates, Inc. (4.68%), Eterna Therapeutics Inc. (1.15%), Biofrontera Inc. (0.75%), NuCana plc (1.21%), Trevena, Inc. (0.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Galera Therapeutics stock? Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galera Therapeutics? A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further. How often is Galera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ADXN Short Interest AEZS Short Interest ATHE Short Interest CMMB Short Interest GHSI Short Interest MTEM Short Interest ERNA Short Interest BFRI Short Interest NCNA Short Interest TRVN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRTX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMost important medical advance in 100 yearsThe Oxford Club